A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency
Clinical trial NCT04615273 · COMPLETED
Trial details
- NCT number
- NCT04615273
- Sponsor
- Ascendis Pharma Endocrinology Division A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-03
- Primary completion
- 2023-11-02
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.